Dr Andrea Pfeifer (AC Immune)

  • Antibodies,Or,Immunoglobulin,Protein,Or,Enzyme,Molecular,Structure,,Chain,Of
    Article

    A novel class of drug candidates for neurodegenerative diseases

    2024-09-11T10:00:55

    At AAIC 2024, AC Immune unveiled a new class of antibody drug conjugates, called morADC (Morphomer® antibody drug conjugate). In this Q&A, CEO of AC Immune, Andrea Pfeifer, discusses how morADC uses the capabilities of the company’s two discovery platforms to combine two highly selective molecules, resulting in drug candidates ...